If You Were Mercks' CEO
If you were Mercks' CEO, what would you do with Rida over the next few months?
1- Would you "stand pat"? Not extend any of the clinical trials until you find out for certain that the FDA has approved Rida for Sarcoma?
2- Agressively seek to expand the usefullness of RIDA by initiating Phase 3 trials in Endo, Breast and or Prostate, believing that Rida will be cleared by the FDA to treat Sarcoma, and therefore reducing the time it will take to extend the indications for Rida.?
3- Stand pat and while you are awaiting the final results for the success trial, make a move to buy Aria?
If you were Mercks' CEO Hmmmmmmmm
Barry
